{
  "trial_id": "NCT02241109",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Patient referred to routine clinical echocardiography at the Department of Cardiology, Inselspital Bern",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Aortic sclerosis with or without stenosis",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Written informed consent",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Any aortic valvular disease other than degenerative sclerotic, bi- or unicuspid valves",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Known disease with expected survival <1 year",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Known malignant tumor",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Subvalvular obstruction (in LVOT) with mean pressure gradient >10mmHg",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Echocardiography",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Patients will be examined by standard echocardiography including a comprehensive assessment of cavity and wall dimensions, ventricular and valvular function, morphologic appraisal and pressure predictions.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "T50-Test The addition of calcium and phosphate to serum triggers the formation of primary calciprotein particles (CPP, see figures 2 and 3). As nano-suspension of calcium-phosphate, these particles represent a defense mechanism of the serum against calcification. Primary CPPs undergo spontaneous transition to secondary CPPs. The formation of these particles represents calcification. In the T50-Test, the time elapsed for the transformation of 50% of the particles is measured and is specific for individual sera.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Age <18 years",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Age <18 years",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "Patient with aortic stenosis, hypertension, hyperlipidemia, and tobacco abuse who presented to his cardiologist with progressive shortness of breath and lower extremity edema. TTE revealed severe aortic stenosis with worsening left ventricular function.",
  "_meta": {
    "topic_id": "2",
    "trial_id": "NCT02241109",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_test10_top50"
  }
}